In a similar mechanism, DPP-4 inhibitors were found to reverse drug-resistance via ABC transporters-mediated CXCL12/CXCR4/mTOR/TGFβ axis in BC cells (Li et al., 2020). The gene discussed is ABCG2; the disease is breast cancer.